As a ''hard'' trivalent metal ion, Al3+ binds strongly to oxygen-donor
ligands such as citrate and phosphate. The aqueous coordination chemi
stry of Al is complicated by the tendency of many Al complexes to hydr
olyze and form polynuclear species, many of which are sparingly solubl
e. Thus there is considerable variation among the Al stability constan
ts reported for several important ligands. The complexity in the aqueo
us chemistry of Al has also affected Al toxicity studies, which have o
ften utilized poorly characterized Al stock solutions. Serum fractiona
tion studies show that most Al is protein bound, primarily to the seru
m iron transport protein transferrin. Albumin appears to play little,
if any, role in serum transport. There is little agreement as to the s
peciation of the remaining low-molecular-mass fraction of serum Al. Th
e lability of the Al3+ ion precludes the simple separation and identif
ication of individual Al complexes. Computational methods are availabl
e for detailed computer calculations of the Al speciation in serum, bu
t efforts in this area have been severely hampered by the uncertaintie
s regarding the stability constants of the low molecular mass Al compl
exes with Citrate, phosphate, and hydroxide. Specific recommendations
for further research on Al speciation include: (1) Determine more accu
rate Al stability constants with critical low molecular mass ligands s
uch as citrate and phosphate; (2) supplement traditional potentiometri
c studies on Al complexes with data from other techniques such as Al-2
7-NMR and accelerator mass spectrometry with Al-26; (3) develop new me
thods for generating reliable linear free energy relationships for Al
complexation; (4) determine equilibrium and rate constants for Al bind
ing to transferrin al 37 degrees C; (5) confirm the possible formation
of low-molecular-mass Al-protein complexes following desferrioxamine
therapy; (6) continue research efforts to incorporate kinetic consider
ations into the present equilibrium speciation calculations; (7) impro
ve methods for preparing chemically well-defined stock solutions for t
oxicological studies; (8) incorporate more detailed speciation data in
to studies on Al toxicity and pharmacokinetics; and (9) incorporate mo
re detailed speciation data into future epidemiological studies on the
relationship between Al toxicity and various water quality parameters
.